# Cost-effectiveness and Safety of the CADScorSystem in Patients With Symptoms Suggestive of Stable Coronary Artery Disease.

Study · id `cardio:ct-nct04121949` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04121949](<https://clinicaltrials.gov/study/NCT04121949>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04121949

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2016 participants.

## Technical summary

Registry record NCT04121949. Randomized; single masking; primary purpose diagnostic. Start 2019-07-01 (actual); primary completion 2023-09-15 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 2016 participants (enrolled count; ClinicalTrials.gov record NCT04121949, source copy `cardio:ctgov-nct04121949-2023-10-05`, retrieved 2026-10-26)
- Started: 2019-07-01 (actual) (ClinicalTrials.gov record NCT04121949, source copy `cardio:ctgov-nct04121949-2023-10-05`, retrieved 2026-10-26)
- Primary completion: 2023-09-15 (actual) (ClinicalTrials.gov record NCT04121949, source copy `cardio:ctgov-nct04121949-2023-10-05`, retrieved 2026-10-26)
- Completion: 2023-09-15 (actual) (ClinicalTrials.gov record NCT04121949, source copy `cardio:ctgov-nct04121949-2023-10-05`, retrieved 2026-10-26)
- Countries: Denmark; Sweden (ClinicalTrials.gov record NCT04121949, source copy `cardio:ctgov-nct04121949-2023-10-05`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04121949-2023-10-05`, retrieved 2026-10-26)

## The registry's words

- Brief title: Cost-effectiveness and Safety of the CADScorSystem in Patients With Symptoms Suggestive of Stable Coronary Artery Disease.
- Acronym: FILTER-SCAD
- Condition: Angina, Stable
- Intervention (Device): CADScor®System
- Lead sponsor: Bispebjerg Hospital
- Lead sponsor class: OTHER
- Collaborator: Region Hovedstadens Apotek
- Collaborator class: OTHER\_GOV
- Collaborator: Larix A/S
- Collaborator class: INDUSTRY
- Collaborator: Acarix
- Collaborator class: INDUSTRY
- Collaborator: Kai Hansen Foundation
- Collaborator class: OTHER
- Collaborator: Kai Houmann Nielsens Fond
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Stable angina (`cardio:stable-angina`)
- Registry lists this organization as the lead sponsor: Bispebjerg Hospital (`cardio:org-bispebjerg-hospital`)

## Provenance

Content hash: 5678102dd6b244118c7cedf19e28c8050676a7819fe2d513e74bae3ea63e2dda
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
